Key distinction

Hypertensive urgency

• Confirm BP with proper technique and repeat measurement.
• Look for triggers: missed BP medications, pain, anxiety, stimulants such as cocaine/amphetamines, NSAIDs, withdrawal from clonidine, etc.
• Do not rapidly normalize BP. Abrupt reduction can reduce perfusion to the brain, heart, or kidneys.
• Usually restart or intensify long-term oral antihypertensives and arrange prompt follow-up, often within days to a week.

Hypertensive emergency

• Hypertensive encephalopathy: confusion, seizures, altered mental status
• Acute ischemic stroke or intracranial hemorrhage
• Acute pulmonary edema / acute left ventricular failure: severe breathlessness, hypoxia
• Acute coronary syndrome: chest pain, myocardial ischemia
• Aortic dissection: abrupt severe chest, back, or abdominal pain
• Acute kidney injury, hematuria, oliguria
• Eclampsia or severe preeclampsia
• Microangiopathic hemolytic anemia

Latest major guidance

Core treatment recommendations

1. Confirm acute target-organ damage and admit to a monitored setting
   • ICU or equivalent, continuous BP monitoring, IV access, frequent neurologic and cardiopulmonary assessment.
   • Assess for encephalopathy, ischemic or hemorrhagic stroke, acute heart failure/pulmonary edema, acute coronary syndrome, aortic dissection, acute kidney injury, retinal injury, microangiopathic hemolysis, and pregnancy-related severe hypertension.
2. Use titratable IV therapy, not rapid oral loading
   • Common first-line IV options: nicardipine, clevidipine, labetalol, esmolol, nitroglycerin, and sometimes sodium nitroprusside.
   • Select the agent based on the target-organ syndrome and contraindications.
3. Avoid excessive early BP reduction
   • For most hypertensive emergencies without a condition-specific target, reduce BP by no more than about 25% in the first hour, then lower gradually over the following 24-48 hours.
   • The purpose is to limit ongoing organ injury while avoiding cerebral, coronary, and renal hypoperfusion in people with chronic hypertension. The 2025 guideline notes that evidence outside stroke/ICH is limited and supports this conservative, individualized approach.
4. Do not treat isolated severe BP as an emergency
   • Severe BP elevation without acute organ damage is no longer best managed by reflex IV or short-acting oral therapy. The 2025 AHA/ACC guideline advises against intermittent IV or oral treatment solely to acutely lower BP in nonpregnant, nonstroke hospitalized patients without acute target-organ damage.

Condition-specific treatment priorities

Practical drug selection

• Nicardipine or clevidipine: useful in many neurologic emergencies because they are titratable arterial vasodilators.
• Labetalol: useful when tachycardia is present and in many neurologic or pregnancy-related settings, but avoid or use carefully in acute decompensated heart failure, bradycardia, heart block, or severe bronchospasm.
• Esmolol: preferred initial agent in aortic dissection due to rapid beta-blockade.
• Nitroglycerin: especially useful for pulmonary edema or myocardial ischemia.
• Nitroprusside: effective but generally reserved for selected settings because of toxicity concerns and need for careful monitoring, particularly in renal or hepatic dysfunction.

Important cautions

• A BP value alone does not define an emergency. Acute organ injury does.
• Do not use immediate-release sublingual nifedipine for nonpregnancy hypertensive emergencies because an uncontrolled BP fall can cause ischemia.
• Stroke, aortic dissection, and pregnancy-related severe hypertension have condition-specific targets that override the generic initial 25% reduction framework.
• Severe chest or back pain, focal weakness, confusion, seizure, acute dyspnea, visual loss, or reduced urine output with markedly elevated BP requires emergency assessment.

• Confirm it is plain Neurobion, not a combination product containing an NSAID such as diclofenac. Products like Dolo-Neurobion are different and NSAIDs can raise BP, cause fluid retention, and worsen kidney function.
• Avoid it if there is a known allergy to B vitamins or the injection ingredients. Rarely, injectable thiamine can cause a serious allergic reaction.
• Long-term or high-dose B6 can cause peripheral neuropathy.
• A person with uncontrolled BP or symptoms of hypertensive emergency should have that evaluated first. Neurobion will not treat high BP, chest pain, breathlessness, weakness, severe headache, confusion, or vision change.
• It should be used for a clear indication, such as proven or suspected B-vitamin deficiency or selected neuropathies, and administered by a trained clinician.